FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

R Vyzula

Research Profile

Geographic Areas

Czech Republic

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Gene Expression Regulation, Neoplastic

Co-author Network

Publications

TOP 3
Ondrej Slaby; Marek Svoboda; Anna Vasku; Julie Bienertova-Vasku; Svatava Bischofová; Veronika Brezkova; Renata Hezova; Alena Kovarikova; Milana Sachlova; Sabina Sevcikova; R Vyzula
Identification of MicroRNAs Regulated by Isothiocyanates and Association of Polymorphisms Inside Their Target Sites with Risk of Sporadic Colorectal Cancer.
Martina Redova; Marek Svoboda; R Vyzula; Andrej Besse; Jan Dolezel; Robert Iliev; Radek Lakomy; Jana Nekvindova; Alexandr Poprach; Lenka Radova; Ondrej Slaby
MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
T Büchler; J Finek; J Hájek; I Kocák; K Kubácková; R Lakomý; B Melichar; L Petruzelka; A Poprach; M Siffnerová; Jirí Tomásek; R Vyzula; Milada Zemanová
[In Process Citation].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of R Vyzula (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ondrej Slaby; Marek Svoboda; Anna Vasku; Julie Bienertova-Vasku; Svatava Bischofová; Veronika Brezkova; Renata Hezova; Alena Kovarikova; Milana Sachlova; Sabina Sevcikova; R Vyzula
Identification of MicroRNAs Regulated by Isothiocyanates and Association of Polymorphisms Inside Their Target Sites with Risk of Sporadic Colorectal Cancer.
Nutrition and cancer 2013;65(2):247-54.
2013: Martina Redova; Marek Svoboda; R Vyzula; Andrej Besse; Jan Dolezel; Robert Iliev; Radek Lakomy; Jana Nekvindova; Alexandr Poprach; Lenka Radova; Ondrej Slaby
MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013;34(1):481-91.
2013: T Büchler; J Finek; J Hájek; I Kocák; K Kubácková; R Lakomý; B Melichar; L Petruzelka; A Poprach; M Siffnerová; Jirí Tomásek; R Vyzula; Milada Zemanová
[In Process Citation].
Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti 2013;26(1):55-7.
2012: Petra Faltejskova; Igor Kiss; Lenka Kubiczkova; Sabina Sevcikova; Jan Smarda; Marek Svoboda; R Vyzula; Andrej Besse; Ondrej Slaby
Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells.
International journal of colorectal disease 2012;27(11):1401-8.
2012: Petra Faltejskova; Igor Kiss; Jitka Mlcochova; Jana Nekvindova; Lenka Radova; Katerina Slaba; Andrej Besse; Pavel Fabian; Klara Srutova; Marek Svoboda; R Vyzula; Ondrej Slaby
Identification and functional screening of microRNAs highly deregulated in colorectal cancer.
Journal of cellular and molecular medicine 2012;16(11):2655-66.
2012: Marek Svoboda; Svatopluk Dobes; Igor Kiss; Alexandr Poprach; R Vyzula
Cardiac toxicity of targeted therapies used in the treatment for solid tumours: a review.
Cardiovascular toxicology 2012;12(3):191-207.
2012: Ondrej Slaby; Marek Svoboda; Robert Iliev; Radek Lakomy; Jana Nekvindova; Alexandr Poprach; Lenka Radova; Martina Redova; R Vyzula
Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.
Genes, chromosomes & cancer 2012;51(7):707-16.
2012: R Demlova; R Obermannova; Dalibor Valik; R Vyzula
Phase I trial in oncology--theory and practice.
Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti 2012;25 Suppl 2():2S98-101.
2012: Petra Faltejskova; Igor Kiss; Milana Sachlova; Marek Svoboda; R Vyzula; Ondrej Bocanek; Ondrej Slaby
Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: Evidence against their usage as biomarkers in colorectal cancer.
Cancer biomarkers : section A of Disease markers 2012;12(4):199-204.
2012: Marek Svoboda; R Vyzula; Pavel Fabian; Jana Gombosova; Ilona Kocakova; Jana Nekvindova; Lenka Radova; Jiri Sana; Ondrej Slaby
MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
Radiation oncology (London, England) 2012;7():195.
2012: A Poprach; Z Bortlíček; T Büchler; Ladislav Dusek; R Vyzula
[The RENIS clinical registry].
Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti 2012;25(4):299-301.
2012: P Grell; K Hejduk; R Vyzula
[BREAST registry].
Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti 2012;25(3):216-8.
2012: M Svoboda; B Syptáková; O Bílek; P Fabian; J Gombošová; P Grell; R Héžová; J Juráček; T Kazda; A Kudláček; J Navrátil; Rudolf Nenutil; M Palácová; A Poprach; P Pospíšil; D Princ; I Selingerová; O Slabý; L Slámová; R Vyzula
[Triple-negative breast cancer: analysis of patients diagnosed and/or treated at the Masaryk Memorial Cancer Institute between 2004 and 2009].
Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti 2012;25(3):188-98.
2012: Renata Hezova; Igor Kiss; Lenka Radová; Milana Sachlova; Julie Bienertova-Vasku; Veronika Brezkova; Marek Svoboda; Anna Vasku; R Vyzula; Ondrej Slaby
Common polymorphisms in GSTM1, GSTT1, GSTP1, GSTA1 and susceptibility to colorectal cancer in the Central European population.
European journal of medical research 2012;17():17.
2012: A Jurecková; I Kocáková; R Vyzula
[GIST registry].
Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti 2012;25(2):135-8.
2012: Marek Svoboda; Pavel Fabian; Jiri Navratil; Marketa Palacova; Martina Redova; Jiri Sana; Ondrej Slaby; R Vyzula
MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.
Diagnostic pathology 2012;7():31.
2012: J Sana; S Hankeova; Igor Kiss; M Svoboda; R Vyzula; Ondrej Slaby
Expression levels of transcribed ultraconserved regions uc.73 and uc.388 are altered in colorectal cancer.
Oncology 2012;82(2):114-8.
2010: Ondrej Slaby; Milana Sachlova; Marketa Bednarikova; Pavel Fabian; Marek Svoboda; Simona Vytopilova; Dalibor Valik; R Vyzula
Gene expression of somatostatin receptor 4 predicts clinical outcome of patients with metastatic neuroendocrine tumors treated with somatostatin analogs.
Cancer biotherapy & radiopharmaceuticals 2010;25(2):237-43.
2006: R Vyzula; I Kocáková; R Demlová; Igor Kiss; Ladislav Dusek; Jirí Jarkovský
Raltitrexed plus oxaliplatin in the second-line treatment of metastatic colorectal cancer.
Neoplasma 2006;53(2):119-27.
2004: R Vyzula; Ladislav Dusek; Jan Zaloudík; R Demlová; D Klimes; S Selvekerová
Breast cancer and neoadjuvant therapy: any predictive marker?
Neoplasma 2004;51(6):471-80.
2003: I Kocáková; I Kocák; R Vyzula; Hana Perková
[Concomitant preoperative chemoradiotherapy in the treatment of anal carcinoma].
Casopís lékar̆ů c̆eských 2003;142 Suppl 1():36-9.
2003: I Kocáková; J Růzicková; I Kocák; R Vyzula
[Role of concomitant chemoradiotherapy in the treatment algorithm for rectal carcinoma].
Casopís lékar̆ů c̆eských 2003;142 Suppl 1():32-5.
2003: I Kocáková; H Vetchá; Renata Soumarová; R Vyzula
[Role of adjuvant chemoradiotherapy in the treatment of gastric carcinoma].
Casopís lékar̆ů c̆eských 2003;142 Suppl 1():26-8.
2003: I Kocáková; Renata Soumarová; I Kocák; R Vyzula
[Review of combined chemoradiotherapy in the treatment of esophageal carcinoma].
Casopís lékar̆ů c̆eských 2003;142 Suppl 1():22-5.
2001: Igor Kiss; J Marková; Jirí Tomásek; R Vyzula; Vlastimil Válek; J Boudný; Zdenek Kala; Ivo Hanke; T Ostrízek; J Leypold
[Personal experience with intra-arterial locoregional chemotherapy of liver metastases from colorectal carcinoma].
Vnitr̆ní lékar̆ství 2001;47(12):829-33.
2001: Igor Kiss; Jan Zaloudík; R Vyzula; Jirí Tomásek; Jan Malaska; O Coufal; I Kocáková
[In vitro testing for drug resistance and drug sensitivity in clinical oncology].
Vnitr̆ní lékar̆ství 2001;47(9):621-6.
2001: Jan Zaloudík; E Geryk; R Vyzula; Ladislav Dusek
[Trends in cancer incidence in the Czech Republic].
Vnitr̆ní lékar̆ství 2001;47(8):516-8.
2001: R Vyzula; Jan Zaloudík; Ladislav Dusek; I Vermousek
Seasonal variation in estrogen and progesterone receptor levels in breast cancer--a factor in data interpretation.
Neoplasma 2001;48(1):19-25.